Cahill Represents Initial Purchasers in $675 Million Notes Offering for Ortho-Clinical Diagnostics S.A. and Ortho-Clinical Diagnostics, Inc.
Date: 01/27/20
Cahill represented the initial purchasers in connection with a Rule 144A offering of $675,000,000 aggregate principal amount of 7.250% senior notes due 2028 by Ortho-Clinical Diagnostics S.A. and Ortho-Clinical Diagnostics, Inc. Proceeds from the offering were used to refinance existing indebtedness and for general corporate purposes.